- Home
- Medical
- Cardiology
- Thrombosis and Thromboembolism
Thrombosis and Thromboembolism
List Price:
$82.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Samuel Z. Goldhaber, Paul M. Ridker
Format:
Paperback
Pages:
392
Publisher:
CRC Press (September 5, 2019)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9780367396527
Weight:
25.875oz
Dimensions:
6" x 9"
File:
TAYLORFRANCIS-TayFran_260415045548659-20260415.xml
Folder:
TAYLORFRANCIS
List Price:
$82.99
Country of Origin:
United States
Pub Discount:
30
Case Pack:
1
As low as:
$78.84
Publisher Identifier:
P-CRC
Discount Code:
H
Imprint:
CRC Press
Overview
Written and edited by world-renowned leaders in the field!
Presents new directions for the prevention and treatment of arterial and venous cardiovascular thrombotic and thromboembolic diseases.
Updates contemporary thinking regarding low-molecular-weight-heparins (LMWH), platelet receptor antagonists, and direct thrombin inhibitors to manage acute coronary syndromes.
Evaluates contemporary strategies for anticoagulation and antiplatelet therapy to improve early clinical outcomes following percutaneous coronary intervention.
Offering diagnostic and management strategies to reduce morbidity and mortality from acute coronary syndromes and acute pulmonary embolism, Thrombosis and Thromboembolism is a superb reference for cardiologists, internists, primary care physicians, vascular medicine specialists, vascular surgeons, hematologists, pulmonologists and critical care physicians, cardiovascular surgeons, cardiac care nurses, and upper-level undergraduate, graduate, and medical school students in these disciplines.
Presents new directions for the prevention and treatment of arterial and venous cardiovascular thrombotic and thromboembolic diseases.
Updates contemporary thinking regarding low-molecular-weight-heparins (LMWH), platelet receptor antagonists, and direct thrombin inhibitors to manage acute coronary syndromes.
Evaluates contemporary strategies for anticoagulation and antiplatelet therapy to improve early clinical outcomes following percutaneous coronary intervention.
Offering diagnostic and management strategies to reduce morbidity and mortality from acute coronary syndromes and acute pulmonary embolism, Thrombosis and Thromboembolism is a superb reference for cardiologists, internists, primary care physicians, vascular medicine specialists, vascular surgeons, hematologists, pulmonologists and critical care physicians, cardiovascular surgeons, cardiac care nurses, and upper-level undergraduate, graduate, and medical school students in these disciplines.
